1. Home
  2. PRME vs UNTY Comparison

PRME vs UNTY Comparison

Compare PRME & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.06

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$60.57

Market Cap

539.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
UNTY
Founded
2019
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
539.4M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
PRME
UNTY
Price
$3.06
$60.57
Analyst Decision
Buy
Buy
Analyst Count
6
2
Target Price
$7.56
$65.00
AVG Volume (30 Days)
2.5M
51.4K
Earning Date
05-08-2026
04-14-2026
Dividend Yield
N/A
1.23%
EPS Growth
18.18
39.66
EPS
N/A
2.82
Revenue
$4,632,000.00
N/A
Revenue This Year
$7.06
$12.14
Revenue Next Year
$47.01
$9.56
P/E Ratio
N/A
$21.59
Revenue Growth
55.28
N/A
52 Week Low
$2.67
$44.34
52 Week High
$6.94
$62.50

Technical Indicators

Market Signals
Indicator
PRME
UNTY
Relative Strength Index (RSI) 45.78 58.92
Support Level $2.73 $51.27
Resistance Level $3.32 N/A
Average True Range (ATR) 0.18 1.11
MACD 0.02 0.08
Stochastic Oscillator 54.62 58.91

Price Performance

Historical Comparison
PRME
UNTY

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

Share on Social Networks: